Simcha Therapeutics

New Haven, United States

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

$40.0M raised

Jan 2022

Series B

Biotechnology Life Science Pharmaceutical Therapeutics

Top Investors

HSG Connecticut Innovations Samsara BioCapital Rock Springs Capital SR One

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Simcha Therapeutics

How much funding has Simcha Therapeutics raised?

Simcha Therapeutics has raised $40.0M in total funding. The most recent round was Series B. The last funding was announced in January 2022.

Who are Simcha Therapeutics's investors?

Simcha Therapeutics's investors include HSG, Connecticut Innovations, Samsara BioCapital, Rock Springs Capital, SR One.

Where is Simcha Therapeutics headquartered?

Simcha Therapeutics is headquartered in New Haven, United States.

What does Simcha Therapeutics do?

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

What stage is Simcha Therapeutics at?

Simcha Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 27, 2022.

MLA

"Simcha Therapeutics — Funding & Investors." VCBacked, January 27, 2022, https://www.vcbacked.co/company/simcha-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2022). Simcha Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/simcha-therapeutics

Wikipedia (cite web)

{{cite web |title=Simcha Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/simcha-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 27, 2022.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K